In addition, ApoA-I has been shown to alter cancer cell metabolism (Zamanian-Daryoush et al., 2020), and this may indirectly mediate the M1 phenotype observed in TAMs when tumor-bearing mice are administered ApoA-I. This evidence concerns the gene APOA1 and cancer.